Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dora Pinto

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|April 14, 2021
Structural basis for broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.
Science (New York, N.Y.)|August 4, 2021
Broad betacoronavirus neutralization by a stem helix-specific human antibodyDora Pinto, Maximilian M Sauer, Nadine Czudnochowski, et al.
Nature|September 6, 2021
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionPetra Mlcochova, Steven A Kemp, Mahesh Shanker Dhar, et al.
Science (New York, N.Y.)|October 20, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Cell|October 9, 2024
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversificationLaura E Rosen, M Alejandra Tortorici, Anna De Marco, et al.
Nature|January 11, 2022
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, John E Bowen, Laura E Rosen, et al.
Biorxiv : the Preprint Server for Biology|December 21, 2021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, Christian Saliba, John E Bowen, et al.
Nature|July 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|April 14, 2021
Structural basis for broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.
Science (New York, N.Y.)|August 4, 2021
Broad betacoronavirus neutralization by a stem helix-specific human antibodyDora Pinto, Maximilian M Sauer, Nadine Czudnochowski, et al.
Nature|September 6, 2021
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionPetra Mlcochova, Steven A Kemp, Mahesh Shanker Dhar, et al.
Science (New York, N.Y.)|October 20, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Cell|October 9, 2024
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversificationLaura E Rosen, M Alejandra Tortorici, Anna De Marco, et al.
Nature|January 11, 2022
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, John E Bowen, Laura E Rosen, et al.
Biorxiv : the Preprint Server for Biology|December 21, 2021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, Christian Saliba, John E Bowen, et al.
Nature|July 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Pageof 5